Literature DB >> 25990292

Metastatic Colorectal Cancer and the Need for More Endoscopic Tools.

Juan E Corral1, Carlos R Diaz, Kalyan R Bhamidimarri.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25990292     DOI： 10.1007/s12029-015-9733-0

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  9 in total

1.  Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases.

Authors:  Michel Gonzalez; John Henri Robert; Nermin Halkic; Gilles Mentha; Arnaud Roth; Thomas Perneger; Hans Beat Ris; Pascal Gervaz
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

2.  Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction.

Authors:  Atif Saleem; Cadman L Leggett; M Hassan Murad; Todd H Baron
Journal:  Gastrointest Endosc       Date:  2011-06-17       Impact factor: 9.427

Review 3.  Emerging treatments in recurrent and metastatic colorectal cancer.

Authors:  Kristen Keon Ciombor; Tanios Bekaii-Saab
Journal:  J Natl Compr Canc Netw       Date:  2013-09       Impact factor: 11.908

Review 4.  Colorectal cancer.

Authors:  David Cunningham; Wendy Atkin; Heinz-Josef Lenz; Henry T Lynch; Bruce Minsky; Bernard Nordlinger; Naureen Starling
Journal:  Lancet       Date:  2010-03-20       Impact factor: 79.321

5.  Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial.

Authors:  Masayuki Kitano; Yukitaka Yamashita; Kiyohito Tanaka; Hideyuki Konishi; Shujiro Yazumi; Yoshitaka Nakai; Osamu Nishiyama; Hiroyuki Uehara; Akira Mitoro; Tsuyoshi Sanuki; Makoto Takaoka; Tatsuya Koshitani; Yoshifumi Arisaka; Masatsugu Shiba; Noriyuki Hoki; Hideki Sato; Yuichi Sasaki; Masako Sato; Kazunori Hasegawa; Hideaki Kawabata; Yoshihiro Okabe; Hidekazu Mukai
Journal:  Am J Gastroenterol       Date:  2013-09-17       Impact factor: 10.864

6.  FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.

Authors:  Volker Heinemann; Ludwig Fischer von Weikersthal; Thomas Decker; Alexander Kiani; Ursula Vehling-Kaiser; Salah-Eddin Al-Batran; Tobias Heintges; Christian Lerchenmüller; Christoph Kahl; Gernot Seipelt; Frank Kullmann; Martina Stauch; Werner Scheithauer; Jörg Hielscher; Michael Scholz; Sebastian Müller; Hartmut Link; Norbert Niederle; Andreas Rost; Heinz-Gert Höffkes; Markus Moehler; Reinhard U Lindig; Dominik P Modest; Lisa Rossius; Thomas Kirchner; Andreas Jung; Sebastian Stintzing
Journal:  Lancet Oncol       Date:  2014-07-31       Impact factor: 41.316

7.  Outcomes in patients with obstructive jaundice from metastatic colorectal cancer and implications for management.

Authors:  Shawnn D Nichols; Scott Albert; Lawrence Shirley; Carl Schmidt; Sherif Abdel-Misih; Samer El-Dika; J Royce Groce; Christina Wu; Richard M Goldberg; Tanios Bekaii-Saab; Mark Bloomston
Journal:  J Gastrointest Surg       Date:  2014-10-10       Impact factor: 3.452

8.  TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial.

Authors:  Takayuki Yoshino; Nobuyuki Mizunuma; Kentaro Yamazaki; Tomohiro Nishina; Yoshito Komatsu; Hideo Baba; Akihito Tsuji; Kensei Yamaguchi; Kei Muro; Naotoshi Sugimoto; Yasushi Tsuji; Toshikazu Moriwaki; Taito Esaki; Chikuma Hamada; Takanori Tanase; Atsushi Ohtsu
Journal:  Lancet Oncol       Date:  2012-08-28       Impact factor: 41.316

Review 9.  Palliative biliary stents for obstructing pancreatic carcinoma.

Authors:  A C Moss; E Morris; P Mac Mathuna
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.